These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 33014519)

  • 1. Emotional Lability at Disease Onset Is an Independent Prognostic Factor of Faster Disease Progression in Amyotrophic Lateral Sclerosis.
    Barć K; Szacka K; Nieporęcki K; de Carvalho M; Gromicho M; Grosskreutz J; Petri S; Rödiger A; Steinbach R; Uysal H; Kuźma-Kozakiewicz M
    Aging Dis; 2020 Oct; 11(5):1021-1028. PubMed ID: 33014519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What does the ALSFRS-R really measure? A longitudinal and survival analysis of functional dimension subscores in amyotrophic lateral sclerosis.
    Rooney J; Burke T; Vajda A; Heverin M; Hardiman O
    J Neurol Neurosurg Psychiatry; 2017 May; 88(5):381-385. PubMed ID: 27888187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Analysis of disease progression rate and related factors in amyotrophic lateral sclerosis patients at initial visit].
    Zhang JH; Wang HF; Yang F; He ZQ; Feng F; Li M; Bai JM; Wang HR; Huang XS
    Zhonghua Yi Xue Za Zhi; 2022 Jan; 102(3):222-227. PubMed ID: 35042292
    [No Abstract]   [Full Text] [Related]  

  • 4. A retrospective investigation of the relationship between baseline covariates and rate of ALSFRS-R decline in ALS clinical trials.
    Daghlas I; Lever TE; Leary E
    Amyotroph Lateral Scler Frontotemporal Degener; 2018 May; 19(3-4):206-211. PubMed ID: 29260911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time of symptoms beyond the bulbar region predicts survival in bulbar onset amyotrophic lateral sclerosis.
    He Z; Sun B; Feng F; Bai J; Wang H; Wang H; Yang F; Cui F; Huang X
    Neurol Sci; 2022 Mar; 43(3):1817-1822. PubMed ID: 34383162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysphagia in Amyotrophic Lateral Sclerosis: Relationships between disease progression and Fiberoptic Endoscopic Evaluation of Swallowing.
    Fattori B; Siciliano G; Mancini V; Bastiani L; Bongioanni P; Caldarazzo Ienco E; Barillari MR; Romeo SO; Nacci A
    Auris Nasus Larynx; 2017 Jun; 44(3):306-312. PubMed ID: 27569290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trajectories of impairment in amyotrophic lateral sclerosis: Insights from the Pooled Resource Open-Access ALS Clinical Trials cohort.
    Thakore NJ; Lapin BR; Pioro EP;
    Muscle Nerve; 2018 Jun; 57(6):937-945. PubMed ID: 29244213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amyotrophic lateral sclerosis regional progression intervals change according to time of involvement of different body regions.
    Manera U; D'Ovidio F; Cabras S; Torrieri MC; Canosa A; Vasta R; Palumbo F; Grassano M; De Marchi F; Mazzini L; Mora G; Moglia C; Calvo A; Chiò A
    Eur J Neurol; 2023 Apr; 30(4):872-880. PubMed ID: 36617536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between Clinical Parameters and Brain Structure in Sporadic Amyotrophic Lateral Sclerosis Patients According to Onset Type: A Voxel-Based Morphometric Study.
    Kim HJ; de Leon M; Wang X; Kim HY; Lee YJ; Kim YH; Kim SH
    PLoS One; 2017; 12(1):e0168424. PubMed ID: 28095425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brainstem Correlates of Pathological Laughter and Crying Frequency in ALS.
    Tu S; Huang M; Caga J; Mahoney CJ; Kiernan MC
    Front Neurol; 2021; 12():704059. PubMed ID: 34305804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poor emotional well-being is associated with rapid progression in amyotrophic lateral sclerosis.
    Prell T; Steinbach R; Witte OW; Grosskreutz J
    eNeurologicalSci; 2019 Sep; 16():100198. PubMed ID: 31384673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphorylated neurofilament heavy subunit (pNF-H) in peripheral blood and CSF as a potential prognostic biomarker in amyotrophic lateral sclerosis.
    Boylan KB; Glass JD; Crook JE; Yang C; Thomas CS; Desaro P; Johnston A; Overstreet K; Kelly C; Polak M; Shaw G
    J Neurol Neurosurg Psychiatry; 2013 Apr; 84(4):467-72. PubMed ID: 23117489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spread Direction and Prognostic Factors in Limb-Onset Sporadic Amyotrophic Lateral Sclerosis.
    Hu F; Jin J; Jia R; Xiang L; Qi H; Chen X; Dang J
    Eur Neurol; 2016; 75(5-6):244-50. PubMed ID: 27165107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between nutritional status and disease severity using the amyotrophic lateral sclerosis (ALS) functional rating scale in ALS patients.
    Park Y; Park J; Kim Y; Baek H; Kim SH
    Nutrition; 2015; 31(11-12):1362-7. PubMed ID: 26429656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How COVID-19 pandemic changed our management strategies for amyotrophic lateral sclerosis (ALS) patients: Egyptian study.
    Rashed HR
    Egypt J Neurol Psychiatr Neurosurg; 2021; 57(1):80. PubMed ID: 34629844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamic Bayesian networks for stratification of disease progression in amyotrophic lateral sclerosis.
    Gromicho M; Leão T; Oliveira Santos M; Pinto S; Carvalho AM; Madeira SC; De Carvalho M
    Eur J Neurol; 2022 Aug; 29(8):2201-2210. PubMed ID: 35426195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do bulbar-onset amyotrophic lateral sclerosis patients have an earlier respiratory involvement than spinal-onset amyotrophic lateral sclerosis patients?
    Pinto S; Pinto A; De Carvalho M
    Eura Medicophys; 2007 Dec; 43(4):505-9. PubMed ID: 18084174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors affecting longitudinal functional decline and survival in amyotrophic lateral sclerosis patients.
    Watanabe H; Atsuta N; Nakamura R; Hirakawa A; Watanabe H; Ito M; Senda J; Katsuno M; Izumi Y; Morita M; Tomiyama H; Taniguchi A; Aiba I; Abe K; Mizoguchi K; Oda M; Kano O; Okamoto K; Kuwabara S; Hasegawa K; Imai T; Aoki M; Tsuji S; Nakano I; Kaji R; Sobue G
    Amyotroph Lateral Scler Frontotemporal Degener; 2015 Jun; 16(3-4):230-6. PubMed ID: 25548957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing upper limb function with ALSFRS-R in amyotrophic lateral sclerosis patients.
    Pinto S; Gromicho M; de Carvalho M
    Amyotroph Lateral Scler Frontotemporal Degener; 2019 Aug; 20(5-6):445-448. PubMed ID: 31032642
    [No Abstract]   [Full Text] [Related]  

  • 20. Low 25OH Vitamin D Blood Levels Are Independently Associated With Higher Amyotrophic Lateral Sclerosis Severity Scores: Results From a Prospective Study.
    Juntas-Morales R; Pageot N; Marin G; Dupuy AM; Alphandery S; Labar L; Esselin F; Picot MC; Camu W
    Front Neurol; 2020; 11():363. PubMed ID: 32547467
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.